We and others have demonstrated that K13 plays a key role in constitutive NF-κB activity observed in PEL cells [9], [46] and is an oncogenic protein which contribute to lymphoproliferative disorders [11], [47], [48]. The gene discussed is NFKB1; the disease is lymphoproliferative syndrome.